Analysts Conflicted on These Healthcare Names: Cigna (CI), Hims & Hers Health (HIMS) and Omnicell (OMCL)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cigna (CI – Research Report), Hims & Hers Health (HIMS – Research Report) and Omnicell (OMCL – Research Report).
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Cigna (CI)
Bank of America Securities analyst Kevin Fischbeck reiterated a Buy rating on Cigna yesterday and set a price target of $378.00. The company’s shares closed last Thursday at $284.53.
According to TipRanks.com, Fischbeck is a 4-star analyst with an average return of
Currently, the analyst consensus on Cigna is a Strong Buy with an average price target of $328.75, which is a 18.6% upside from current levels. In a report issued on January 22, RBC Capital also maintained a Buy rating on the stock with a $344.00 price target.
See today’s best-performing stocks on TipRanks >>
Hims & Hers Health (HIMS)
In a report released yesterday, Allen Lutz from Bank of America Securities reiterated a Sell rating on Hims & Hers Health, with a price target of $26.00. The company’s shares closed last Thursday at $23.48.
According to TipRanks.com, Lutz is a 5-star analyst with an average return of
Currently, the analyst consensus on Hims & Hers Health is a Hold with an average price target of $38.14.
Omnicell (OMCL)
Wells Fargo analyst Stan Berenshteyn maintained a Buy rating on Omnicell yesterday and set a price target of $52.00. The company’s shares closed last Thursday at $39.08.
According to TipRanks.com, Berenshteyn is ranked 0 out of 5 stars with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Omnicell with a $61.00 average price target, implying a 53.7% upside from current levels. In a report issued on January 21, TipRanks – OpenAI also upgraded the stock to Buy with a $54.00 price target.
